Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry

Publisher： John Wiley & Sons Inc

E-ISSN： 1468-3083|29|5|858-864

ISSN： 0926-9959

Source： JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol.29, Iss.5, 2015-05, pp. : 858-864

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry

By Weaver Arthur L.   Lautzenheiser Richard L.   Schiff Michael H.   Gibofsky Allan   Perruquet James L.   Luetkemeyer John   Paulus Harold E.   Xia H Amy   Leff Jonathan A.    

Current Medical Research and Opinion, Vol. 22, Iss. 1, 2006-01 ,pp. : 185-198

Informa Healthcare

Access to resources Recommend Favorite

Biologic therapies in systemic lupus erythematosus

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 18, Iss. 2, 2015-02 ,pp. : 146-153

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety of Systemic Biologic Agents in the Treatment of Non-malignant Skin Disorders

By  

Current Drug Safety, Vol. 12, Iss. 2, 2017-07 ,pp. : 76-94

Bentham Science Publishers

Access to resources Recommend Favorite

Biologic Therapy in Psoriasis: Safety Profile

By  

Current Drug Safety, Vol. 11, Iss. 1, 2016-03 ,pp. : 4-11

Bentham Science Publishers

Access to resources Recommend Favorite

Observations from our evaluation of bodyweight changes after initiation of a biologic therapy in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 31, Iss. 12, 2017-12 ,pp. : e544-e547

John Wiley & Sons Inc

Access to resources Recommend Favorite